Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

NCT00083980 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
16
Enrollment
NIH
Sponsor class

Stopped European reports of liver toxicity from kava meant that the study had to stop

Conditions

Interventions

Sponsor

National Center for Complementary and Integrative Health (NCCIH)